Prague

Prague has emerged as a premier European hub for the life sciences, distinguished by its seamless integration of pharmaceutical manufacturing and cutting-edge biotechnology.

The city is globally recognized for its leadership in oncology and immunology, anchored by industry giants like SOTIO Biotech and a growing cluster of innovative startups specializing in antibody-drug conjugates (ADCs).

As a center for healthcare innovation, Prague leverages a robust digital infrastructure to advance personalized medicine and AI-driven diagnostics, significantly improving patient outcomes across the CEE region.

The medical device sector remains a cornerstone of the local economy, with a strong focus on high-tech instrumentation and nanotechnology applications.

Academically, the city is powered by prestigious institutions such as Charles University and the Czech University of Life Sciences, which foster a rich talent pipeline and world-class academic research.

Furthermore, Prague’s sophisticated clinical research environment offers a competitive landscape for Phase I-III clinical trials, supported by a high density of specialized hospitals and expert investigators.

This synergy between private enterprise and public research makes the Prague life sciences ecosystem an attractive destination for global investment and biopharma partnerships.

With a strategic focus on eHealth and genomic medicine, the city is effectively shaping the future of European healthcare.